Cardiology Solutions
Virtual-first cardiology practice delivering accessible cardiovascular care nationwide
Platform · Cloud SaaSCompany source
Company profile
About Heartbeat Health
Heartbeat Health is a modern cardiology practice revolutionizing cardiovascular care delivery through virtual-first and hybrid care models. Founded to address the U.S. heart care crisis—where 1 in 3 deaths are caused by cardiovascular disease and 46% of counties lack easy access to cardiologists—Heartbeat delivers evidence-based cardiac care through remote diagnostics, home-based testing, and proactive management. The company operates a network of 1000+ active provider licenses across all 50 states, employing cardiologists, advanced practice providers, registered nurses, and care coordinators who work together to identify and close gaps in cardiovascular care. Heartbeat serves multiple customer segments including health systems, accountable care organizations (ACOs), payers, employer groups, and in-home health assessment organizations. Their care model combines risk stratification using claims data and social determinants of health assessments, home-based diagnostics that eliminate facility fees, coordinated treatment following evidence-based pathways, and continuous outcomes measurement. The company has demonstrated significant clinical outcomes including 90%+ of members reaching target blood pressure, 53% reduction in cardiac-related readmissions, and 85%+ patient satisfaction scores. Heartbeat's approach addresses complex cardiovascular conditions including arrhythmias, heart failure, coronary artery disease, and hypertension through longitudinal virtual care programs supported by peer-reviewed clinical evidence.
Company description Heartbeat Health official website
Primary marketCardiology & Cardiovascular Health
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Heartbeat Health?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- arrhythmias
- ASCVD
- atrial fibrillation
- cardiovascular disease
- coronary artery disease
- diabetes with cardiovascular risk
- heart failure
- hypertension
Who it serves
- ACOs
- Employer Groups
- Health Systems
- In-Home Care Providers
- Medicaid programs
- Medicare Advantage plans
- Payers
Deployment & integration
Cloud Saas · Hybrid deployment with recorded integration context.
Recorded integration context: Redox.
Geographic context
MarketsUnited States (all 50 states)
Company sourceOfficial website
Company milestones
Platform expansion
Growth investment by Cressey & Company (July 2024), partnership with Karoo Health for national cardiac value-based care solution (May 2024), partnership with MedArrive for Medicaid virtual cardiology (August 2023), participation in TRANSFORM trial with Cleerly (November 2023)
Partnerships
Recorded partners
- Cleerly
- Cressey & Company
- Karoo Health
- MedArrive
- Redox
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Cardiac Arrhythmia Screening Program
Large-scale arrhythmia detection program for high-risk primary care patients
Service · HybridCompany source
Remote Patient Monitoring Program
Home-based cardiac monitoring for hypertension and cardiovascular disease management
Platform · HybridCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Direct-to-Participant Enrollment in a Virtual Trial: Lessons Learned From the Heartline Study.JACC. Advances · Apr 1, 2026
Aortic Stenosis With Dynamic Left Ventricular Outflow Obstruction: Diagnostic and Management Challenges-A Case Series.CASE (Philadelphia, Pa.) · Jan 1, 2025
The Introduction of AI Into Decentralized Clinical Trials: Preparing for a Paradigm Shift.JACC. Advances · Aug 1, 2024
A Virtual Cardiovascular Care Program for Prevention of Heart Failure Readmissions in a Skilled Nursing Facility Population: Retrospective Analysis.JMIR cardio · Jun 1, 2021
Clinical validation
Clinical-trial records
Withings ECG-Monitor StudyNCT05316337 · Mentioned · COMPLETED
Withings ECG-app StudyNCT05316350 · Mentioned · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
90%+ members reached target blood pressure
Outpatient members with hypertension in RPM program 2017-2021
53% reduction in cardiac-related readmissions
90-day randomized clinical trial vs standard care
85%+ all-time NPS / top patient satisfaction ratings
Overall patient satisfaction
<50mg/dL average LDL
Heartbeat CAD patients
85% statin adherence
Patients with ASCVD or Diabetes on a statin
Medicare Advantage Population
Post-discharge cardiovascular care management to reduce hospital readmissions
53% reduction in cardiac-related readmissions over 90 days
Hypertension Outpatient Members
Remote patient monitoring for blood pressure management in hypertensive patients
90%+ of members reached target blood pressure
ASCVD and Diabetes Patients
Statin adherence program for cardiovascular disease prevention
85% statin adherence rate among patients with ASCVD or Diabetes
CAD Patient Population
LDL cholesterol management in coronary artery disease patients
Average LDL of <50mg/dL achieved in CAD patients
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Jeff Wessler
Founder & Chief Executive Officer
David Dempsey
President & Chief Operating Officer
Cheri McGregor
Interim Chief Medical Officer
Brian Greer
Chief Legal Officer
Charles Colligan
Chief Financial Officer
Andrew MacGill
Chief Product Officer
Sophia Kim
Chief Growth Officer
Ben Hayon
Chief of Staff
06 · Company updates
Updates from Heartbeat Health
Recent articles published on Heartbeat Health's official website.
Why PCSK9 Inhibitors work so well.
Read on Heartbeat HealthHow Virtual-First Cardiology Is Reshaping the Patient Experience
Read on Heartbeat HealthWhy Virtual-First Cardiology Makes Sense for PACE Programs
Read on Heartbeat HealthPreventive Cardiology: Why Proactive Heart Care Beats Reactive Treatment
Read on Heartbeat HealthListen carefully when a patient tells you: “This is not normal for me.”
Read on Heartbeat Health07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Cardiology & Cardiovascular Health
Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.